---

Summary for the Student/Candidate

---

PART 1 - From the Uploaded Books

1. Introduction and historical background (Torabinejad's development, 1993-1998 FDA approval)
2. Composition - tricalcium silicate, dicalcium silicate, Bi₂O₃ radiopacifier; GMTA vs. WMTA
3. Physical and chemical properties - setting time, pH ~12.5, compressive strength, effect of EDTA/moisture
4. Biocompatibility and mechanism - Sarkar et al. hydroxyapatite interface, Ca(OH)₂ release, osteogenic potential
5. Direct pulp capping - indications, technique steps, MTA vs. Ca(OH)₂ comparison, primary vs. permanent teeth
6. Pulpotomy - primary teeth (MTA vs. formocresol, technique, radiographic outcomes) AND immature permanent teeth (partial/Cvek pulpotomy, full coronal pulpotomy, AAPD definitions)
7. Apexification with MTA apical plug - indications, step-by-step technique, comparison with Ca(OH)₂ method
8. Root perforation repair - Ford et al. 1995, furcal perforations in primary teeth, technique
9. Regenerative endodontics - MTA as coronal plug, REP protocol (Torabinejad Ch. 6)
10. Special applications - primary teeth without successors, dens invaginatus, comparison table with Biodentine/CEM/Portland cement, disadvantages/limitations

---

PART 2 - Literature Support (PubMed Indexed)

• Section A: 13 landmark studies (Torabinejad 1993, 1995, 1999; Ford et al. 1995; Eidelman & Fuks 2001; Holan 2005; Sarkar 2005; Shabahang 1999, 2000; Witherspoon 2001)
• Section B: 12 recent systematic reviews and meta-analyses (2017-2025) with PMIDs, evidence tier ratings, specific clinical findings, and implication statements - covering pulpotomy in primary teeth, DPC in permanent young teeth, apexification
• Section C: Summary evidence table by application
• Section D: Current 2024-2025 status including AAPD guidelines endorsement of MTA, latest bioceramic alternatives
• Section E: Unresolved controversies and areas of ongoing debate
• Section F: Examiner's Quick Recall Checklist for key facts

---

What This Answer Covers

PART 1 - Conceptual and Textbook Foundation (14 detailed sections)

1. Introduction and Definition - what makes a material "smart"; why these properties are especially valuable in pediatric dentistry (high caries risk, behavioral challenges, dynamic dentition, immature mineralization)
2. Classification - five major categories (ion-releasing restoratives, calcium silicate cements, silver-based systems, nanotechnology materials, bioactive glass)
3. GIC - fluoride release mechanism, recharge capability, types (conventional, HVGIC, RMGIC, cermet), pediatric advantages
4. RMGIC - composition, dual-set mechanism, pediatric applications including SSC luting
5. Giomers - S-PRG filler technology, six-ion release profile, Beautifil products, esthetic advantage
6. Compomers - composition, limitations vs. GIC, Dyract AP clinical use
7. Bioactive Resins - ACTIVA BioACTIVE, alkasites (Cention N), pH-responsive ion release
8. Bioactive Glass (NovaMin) - 45S5 composition, remineralization mechanism, hydroxyapatite nucleation
9. Calcium Silicate Cements - MTA and Biodentine as smart bioactive pulp materials
10. SDF - composition, triple mechanism (Ag + F + diamine), protocol, black staining, applications in ECC
11. SMART Technique - SDF + GIC combined approach, protocol, advantages for uncooperative children
12. Nanotechnology materials - nanocomposites, nano-HAp, nano-silver, QAC antimicrobial adhesives
13. Smart Sealants - fluoride-releasing resin sealants, GIC sealants, ART sealants
14. Summary classification table with all materials, ions released, smart trigger, pediatric use, and evidence level

PART 2 - Indexed Literature (25 references, landmark to 2026)

• 5 landmark foundational studies (Wilson & Kent 1972 on GIC; Yamaga 1972 on SDF; Chu 2002; Llodra 2005; Frencken 1996 on ART)
• 17 high-quality systematic reviews, meta-analyses, and RCTs with PMIDs, specific quantitative findings, and clinical implications
• Most current evidence: Cochrane review on SDF (Worthington 2024), meta-analysis on secondary caries prevention (Zailai 2026), SMART RCT (Solh 2026), scoping review on minimally invasive childhood caries (Fortunato 2026)
• Evidence hierarchy table and Quick Recall Checklist

---

MTA IN PEDIATRIC DENTISTRY

Comprehensive Point-Wise Theory Examination Notes

---

PART 1: FROM THE UPLOADED BOOKS

---

1. INTRODUCTION AND HISTORICAL BACKGROUND

• MTA was developed by Dr. Mahmoud Torabinejad at Loma Linda University in the early 1990s; doctoral work supervised by Professor Thomas Pitt Ford.
• Origins trace to civil engineering and the construction industry - it is fundamentally a hydraulic calcium silicate cement derived from Portland cement.
• Commercial introduction of ProRoot MTA began in 1998 by Tulsa Dental Specialties (Dentsply International) after FDA approval. From 1993 to 1998, Dr. Torabinejad distributed experimental samples from his laboratory to endodontists.
• Designed to address the absence of a repair material with ideal characteristics: biocompatibility, superior sealing ability, and ability to set in the presence of moisture.
• Over 1,000 publications exist regarding its properties and clinical efficacy, making it one of the most investigated dental materials in dentistry. (Torabinejad Book, Preface)
• MTA was investigated through a series of tests including: in vitro dye leakage, bacterial leakage, SEM examination for marginal adaptation, setting time, compressive strength, solubility, cytotoxicity, implantation in bone, and animal usage tests. (Torabinejad Book, Preface)

---

2. COMPOSITION

2.1 Chemical Composition

• Primary components:
  • Tricalcium silicate (Ca₃SiO₅)
  • Dicalcium silicate (Ca₂SiO₄)
  • Tricalcium aluminate (Ca₃Al₂O₆)
  • Tetracalcium aluminoferrite (Ca₄Al₂Fe₂O₁₀)
• Radiopacifier: Bismuth oxide (Bi₂O₃) - approximately 20% by weight - this distinguishes MTA from plain Portland cement
• Small amounts of: silicon dioxide, calcium sulfate dihydrate (gypsum)

2.2 Gray MTA (GMTA) vs. White MTA (WMTA)

• Gray MTA (GMTA - original ProRoot): Contains iron-rich tetracalcium aluminoferrite - responsible for the gray color; greater discoloration potential
• White MTA (WMTA - ProRoot White): Reduced iron content, lower aluminoferrite phase - developed to overcome discoloration; preferred in esthetic zones and pediatric anterior teeth

2.3 Hydration Chemistry

2Ca₃SiO₅ + 7H₂O → 3CaO·2SiO₂·4H₂O + 3Ca(OH)₂

2Ca₂SiO₄ + 5H₂O → 3CaO·2SiO₂·4H₂O + Ca(OH)₂

• Products:
  • Calcium silicate hydrate (C-S-H gel) - provides mechanical strength
  • Calcium hydroxide - responsible for bioactivity, alkalinity, and antimicrobial effect
• Bioactive mechanism (Sarkar et al. 2005): Released Ca(OH)₂ reacts with tissue phosphate ions → hydroxyapatite precipitation at tissue interface → explains hermetic biological seal and hard tissue formation (Torabinejad Book, Ch. 2-3)

---

3. PHYSICAL AND CHEMICAL PROPERTIES

3.1 Moisture Requirement

• MTA requires moisture for setting; desiccation during setting is strictly contraindicated - reduces strength and causes incomplete hydration
• ISO 6876 standard for root canal sealers specifies water for water-based cements - this complicates testing; excess water diminishes compressive strength and increases setting time (Camilleri Book, Ch. 1)

3.2 Effect of Irrigating Solutions

• EDTA and BioPure MTAD have the greatest detrimental effect on MTA setting:
  • EDTA chelates released calcium → disrupts calcium silicate hydrate formation → reduces microhardness and flexural strength
  • Any area where MTA will be applied should be flushed thoroughly with distilled water to remove irrigant residues before placement (Torabinejad Book, Ch. 3)
• Set MTA exposed to EDTA for 5 minutes shows surface roughening, calcium extraction, and surface dissolution
• NaOCl, CHX: lesser effects on set MTA; clinical significance likely low given brief contact times

3.3 Effect of pH on MTA

• Microhardness significantly higher at pH 7.4 versus pH 4.4
• Acidic environments (e.g., inflamed tissues, pH 4.4-5.4) reduce setting quality
• Clinical implication: infection must be controlled prior to MTA placement

---

4. BIOCOMPATIBILITY AND MECHANISM OF ACTION

4.1 Physicochemical Basis of Bioactivity (Sarkar et al. 2005 - Cited in Torabinejad Book)

• MTA is bioactive - when in contact with phosphate-containing tissue fluid, it precipitates hydroxyapatite-like crystals on its surface and at the MTA-dentin interface
• Sarkar et al. (2005) first described the interfacial layer between MTA and surrounding dentin:
  • Globular precipitates form on MTA surface when exposed to PBS solution
  • Precipitates are similar to hydroxyapatite by XRD and EDX analysis
  • An interfacial layer forms between MTA and dentin (calcium-phosphorus rich)
  • Mechanism: released Ca²⁺ + tissue PO₄³⁻ → hydroxyapatite → hermetic biological seal
• Addition of CaCl₂ to WMTA significantly increases calcium release in the first 24 hours; however, high local Ca²⁺ concentrations may transiently decrease cell proliferation before stimulating differentiation (Torabinejad Book, Ch. 3)

4.2 Biological Properties

• Biocompatibility: Comparable to calcium hydroxide in cell culture studies; freshly mixed MTA is more cytotoxic than set MTA; set MTA is well-tolerated by periradicular and pulpal tissues
• Antibacterial effect: Strongly alkaline pH (~12.5) is the primary mechanism; less sustained than calcium hydroxide; enhanced when in contact with dentin (dentin enhances antimicrobial effect of MTA - Zhang et al.)
• Osteogenic/cementogenic potential: Upregulates osteoblast-like cell activity; promotes cementum deposition and bone healing at periapical level; supports odontoblast-like cell differentiation
• Hard tissue formation:
  • Induces reparative dentin bridge - more homogeneous and continuous with original dentin compared to calcium hydroxide
  • Bridges formed with MTA show fewer tunnel defects than Ca(OH)₂ bridges
  • Less pulpal inflammation in MTA-treated teeth vs. Ca(OH)₂ in both canine and human in vivo studies (Torabinejad Book, Ch. 4)

---

5. CLINICAL APPLICATIONS IN PEDIATRIC DENTISTRY

---

5.1 INDIRECT PULP CAPPING

• Indicated when a thin layer of carious dentin remains over the pulp; no evidence of irreversible pulpitis or periapical disease
• MTA may be used as a base/liner after stepwise caries excavation; strongly alkaline pH limits residual bacterial growth
• Sahin et al. (2021) RCT evaluating Biodentine, MTA, and Ca(OH)₂ for indirect pulp capping in primary teeth - all materials showed acceptable outcomes but calcium silicate cements produced superior histological responses
• Evidence for MTA in indirect pulp capping is less robust than for direct techniques; calcium hydroxide remains widely used as the comparison material

---

5.2 DIRECT PULP CAPPING (DPC)

Indications

• Mechanical (iatrogenic) or traumatic exposure of vital pulp in a tooth with no signs of irreversible pulpitis or periapical disease
• Carious exposure in a cooperative patient where hemorrhage is controlled in <5 minutes (bright red, not dark blood)
• More conservative than pulpotomy - preserves maximum coronal pulp tissue
• Note: DPC generally not recommended for primary teeth with carious exposures due to high risk of inflammatory resorption and abundant accessory canals in furcation; reserved primarily for mechanical exposures in primary teeth (AAPD position, cited in Torabinejad Book)

Clinical Steps - DPC with MTA

1. Local anesthesia; rubber dam isolation (mandatory)
2. Caries removal under high-speed bur with water cooling; avoid desiccation
3. Hemorrhage assessment: apply sterile saline-moistened cotton pellet with pressure
4. Bleeding must control within 5 minutes for DPC to be appropriate; persistent dark hemorrhage = pulpotomy indicated
5. Mix MTA to a putty-like consistency
6. Apply 1.5-3.0 mm thickness of MTA over the exposure site using small amalgam carrier; tease into place with moist cotton pellet using endodontic pliers
7. Cover with thin layer of flowable glass ionomer or composite; light cure
8. Restore with adhesive/final restoration at same appointment (WMTA allows same-visit restoration)
9. Review at 3, 6, 12 months clinically and radiographically (Torabinejad Book, Ch. 4)

Advantages of MTA over Calcium Hydroxide for DPC

• More consistent dentin bridge formation - thicker, more homogeneous bridges without tunnel defects
• No tunnel defects - Ca(OH)₂ bridges frequently demonstrate tunnel defects (bacterial microleakage pathways)
• Less internal root resorption compared to calcium hydroxide long-term
• No resorption of the material itself - Ca(OH)₂ gradually dissolves leaving voids
• Superior long-term pulp vitality rates
• Bioactive - actively promotes hard tissue through hydroxyapatite interface formation
• Dentin deposition begins earlier with MTA (Abedi et al. 1996; Myers et al. 1996; Pitt-Ford et al. 1996, cited in Torabinejad Book Ch. 4)

---

5.3 PULPOTOMY

5.3.1 Pulpotomy in PRIMARY TEETH

Background

• Formocresol pulpotomy was the historical gold standard for decades
• Concerns about formaldehyde toxicity, mutagenicity, carcinogenicity, systemic absorption, internal root resorption led to search for alternatives
• MTA emerged as a superior, biocompatible, non-fixative alternative to both formocresol and ferric sulfate

Indications

• Vital primary molar with carious pulp exposure
• No clinical/radiographic evidence of irreversible pulpitis or radicular pathology:
  • No spontaneous toothache (history)
  • No furcation radiolucency
  • No pathological root resorption (internal or external)
  • No pain on palpation or percussion
  • No sinus tract or swelling
  • No physiological root resorption beyond 1/3 root length
• Restorable tooth with adequate remaining structure
• Cooperative child (or child rendered cooperative)

Clinical Procedure - MTA Pulpotomy in Primary Teeth

1. Local anesthesia; rubber dam isolation
2. Complete caries removal with high-speed bur
3. Access cavity preparation
4. Coronal pulp amputation using large round bur or sharp spoon excavator - remove entire coronal pulp
5. Irrigate with sterile saline; hemostasis with sterile cotton pellet moistened with saline or dilute NaOCl (~5 min pressure)
6. Assess pulp stumps: Bleeding should be controllable and bright red (not dark = radicular inflammation)
7. Mix MTA to a putty consistency; place over pulp stumps; adapt with moist cotton pellet
8. Thickness of MTA: minimum 2-3 mm covering all canal orifices
9. Place a moist cotton pellet over MTA; close with IRM or GIC temporarily
10. At second appointment (24-48 hours): remove temporary, check MTA has set (firm to explorer)
11. Place GIC base over set MTA; restore with stainless steel crown (SSC) - material of choice to protect against microleakage and tooth fracture
12. Note: some recent protocols allow single-visit completion with WMTA (Torabinejad Book, Ch. 4)

Why MTA Produces Superior Results in Primary Molar Pulpotomy

• Formation of dentin bridge/hard tissue barrier at amputation site - unique to MTA; formocresol and ferric sulfate do NOT predictably induce this
• No formaldehyde - eliminates all toxicity concerns; biocompatible with furcal bone and periradicular tissues
• Less internal root resorption - maintains root architecture until physiological exfoliation
• Maintains furcation integrity - lower incidence of furcation radiolucency on follow-up radiographs
• Promotes healing through bioactive mineralization (hydroxyapatite precipitation) (Torabinejad Book, Ch. 4)

Clinical Outcomes - MTA Pulpotomy in Primary Teeth

• Success rates: 92-97% clinical; 94-97% radiographic at 24 months follow-up
• Significantly lower incidence of:
  • Internal root resorption
  • Furcation radiolucency
  • Periapical pathology compared to formocresol (Doyle et al. 2010, cited in Torabinejad Book; Holan et al. 2005)

---

5.3.2 Pulpotomy in IMMATURE PERMANENT TEETH

Classification

AAPD Definition of Partial Pulpotomy

Goal of Pulpotomy in Immature Permanent Teeth

• Preserve the apical radicular pulp → allow continued apexogenesis (root maturation and apex closure)
• Avoids premature root canal treatment in a tooth with thin, fragile, immature root walls

Clinical Steps - Partial Pulpotomy (MTA) for Immature Permanent Teeth

1. Anesthesia; rubber dam
2. Remove only inflamed pulpal tissue - extend approximately 2 mm into pulp
3. Use round diamond bur at high speed with water cooling
   • Spoon excavators and slow-speed round burs are contraindicated - they tear and cause torsion/contusion of pulp tissue (Torabinejad Book, Ch. 4)
4. Wash with sterile water or physiologic saline; re-examine for clean amputation
5. Hemostasis: Cotton pellets dampened with sodium hypochlorite (SH); pressure for 30-60 seconds
6. If hemorrhage continues → extend amputation deeper into pulp
7. Do not blow excessive air on exposed pulp - causes desiccation tissue damage
8. Once hemostasis achieved: apply MTA 1.5-3.0 mm in thickness over remaining pulp
9. Load MTA in amalgam carrier; partially extrude and remove all but 1-2 mm with plastic instrument; gently place over pulp and tease into place with moist cotton pellet
10. Cover with thin flowable GIC or composite; light cure
11. Complete final restoration at same appointment (Torabinejad Book, Ch. 4)

Results - MTA vs. Calcium Hydroxide for Partial Pulpotomy in Permanent Teeth

• MTA consistently shows better dentin bridging - more homogeneous and continuous with original dentin
• Less pulpal inflammation with MTA in both canine and human in vivo studies (Dominguez et al. 2003; Brisco et al. 2006; Chacko & Kurikose 2006; El-Meligy et al. 2006; Qudeimat et al. 2007; Nair et al. 2008 - all cited in Torabinejad Book)
• Dentin deposition begins earlier with MTA
• Success rates: 93-100% over 24-48 month follow-up (Torabinejad Book, Ch. 4)

---

5.4 APEXIFICATION WITH MTA APICAL PLUG

Background

• Apexification = method to induce apical closure in teeth with necrotic pulps and open, blunderbuss (immature) apices (most commonly maxillary central incisors traumatized in school-age children)
• Traditional Ca(OH)₂ method: Multiple dressing changes over 2-4 years until biological calcific barrier forms; major drawbacks:
  • Long treatment duration (2-4 years); multiple visits; patient compliance issues
  • Risk of root fracture - prolonged Ca(OH)₂ use weakens dentin by hydrolysis of collagen (Torabinejad Book, Ch. 5)
  • Barrier formation unpredictable; must monitor with radiograph each visit
  • Once barrier forms, Ca(OH)₂ does not provide a definitive seal
• MTA apical plug: Creates an immediate, predictable, hard-tissue barrier - single or two-visit apexification

MTA Apical Plug - Concept and Rationale

• MTA is condensed into the apical 4-5 mm of the root canal creating an artificial apical stop
• Strongly alkaline, bioactive MTA:
  • Seals the apex against microleakage (hydroxyapatite precipitation)
  • Stimulates cementum/bone formation at periapex
  • Eliminates waiting time for biological barrier formation
• Linsuwanont (2003): "With MTA, formation of the apical barrier is predictable and it is not necessary to monitor" (cited in Torabinejad Book, Ch. 3)
• Remainder of canal obturated with gutta-percha, composite resin, or MTA full-canal fill (Torabinejad Book, Ch. 5; Camilleri Book, Ch. 6)

Indications

• Immature permanent tooth with necrotic pulp and open apex
• Failed apexogenesis due to pulp necrosis from trauma or deep caries
• Most common: maxillary central incisors - school-age trauma
• Also: non-vital premolars with congenitally absent successors; dens invaginatus with periapical pathology (Camilleri Book, Ch. 6)

Clinical Technique - MTA Apical Plug (Step-by-Step)

1. Access cavity preparation
2. Infection control: Chemo-mechanical debridement with gentle irrigation (dilute NaOCl 1-2.5%); canal enlargement limited by thin immature root walls - avoid unnecessary widening
3. Intracanal Ca(OH)₂ dressing placed for 1-4 weeks to disinfect and reduce bacterial load (some contemporary protocols with initial Ca(OH)₂/TAP skip if tooth initially clean)
4. Second appointment (verification visit):
   • Confirm absence of symptoms and dry canal
   • Remove medicament; re-irrigate gently
   • Determine working length with radiograph/CBCT
5. Mix WMTA to a putty consistency (not too wet or dry)
6. Carry MTA into canal with MTA carrier/Messing Gun or amalgam carrier
7. Compact MTA to apical 4-5 mm using pluggers or dry cotton pellets/paper points
8. Verify apical plug position radiographically - should be 4-5 mm from apex
9. Place moist cotton pellet over MTA; close with IRM or GIC temporarily
10. Allow MTA to set 24-48 hours - cotton pellet ensures moist setting environment
11. At subsequent appointment: verify hardness of MTA with sharp explorer
12. Obturate remaining canal space with composite resin buildup, gutta-percha + sealer, or fill entirely with MTA
13. Restore with adhesive/composite/post if indicated (Torabinejad Book, Ch. 5; Camilleri Book, Ch. 6)

Advantages of MTA Apical Plug over Ca(OH)₂ Apexification

Outcomes

• Success rates: 70-95% in long-term studies with resolution of periapical pathology
• Histological confirmation: cementum-like and bone-like tissue forms at periapex adjacent to MTA
• Landmark animal study (Shabahang & Torabinejad): MTA produced superior apical closure to Ca(OH)₂ and osteogenic protein-1 in dog teeth (Torabinejad Book, Ch. 5)

---

5.5 ROOT PERFORATION REPAIR

Background

• Root perforations in pediatric context result from:
  • (a) Access preparation errors
  • (b) Excessive canal instrumentation
  • (c) Internal or external root resorption
  • (d) Pathological processes (Torabinejad Book, Ch. 7)
• Furcal perforations in primary molars and immature permanent teeth are a specific pediatric concern
• Prior materials (amalgam, IRM, SuperEBA) lacked adequate biocompatibility with furcal/periodontal tissues

MTA for Perforation Repair

• Ford et al. (1995): Landmark clinical study using MTA for repair of furcal perforations; demonstrated significantly better outcomes than amalgam (cited in Torabinejad Book, Ch. 7 and Camilleri Book)
• MTA is the material of choice for furcal perforation repair because:
  • Biocompatibility with furcal/periodontal ligament tissues
  • Sets in the presence of blood and moisture
  • Stimulates periodontal ligament and furcal bone healing
  • Prevents persistent communication between canal system and periodontium
  • Bioactive interface formation (hydroxyapatite)

Key Prognostic Factors for Success

• Size: Smaller perforations = better prognosis
• Time: Immediate repair = superior outcomes (prevent contamination)
• Location: Cervical perforations = poorer prognosis; furcal = intermediate
• Degree of infection/contamination: Less = better

Clinical Technique

1. Identify perforation site radiographically (or with apex locator)
2. Disinfect with NaOCl irrigation; achieve hemostasis with cotton pellets
3. Mix MTA to creamy/putty consistency
4. Place directly into perforation with amalgam carrier or MTA carrier
5. Compact gently - do not push material through perforation into periodontal tissues
6. Cover with moist cotton; seal temporarily; re-examine in 24-48 hours
7. Complete endodontic treatment after MTA verification; restore definitively (Torabinejad Book, Ch. 7)

---

5.6 ROOT-END FILLING (PERIAPICAL SURGERY IN CHILDREN)

• Although less common in children than adults, periapical surgery with root-end filling is indicated when conventional endodontic treatment has failed
• MTA is the material of choice for root-end fillings during apical surgery (Camilleri Book, Ch. 9)

Evidence from Camilleri Book (Chapter 9 - Evidence-Based Practice):

• Song & Kim: MTA (95.6%) vs. Super EBA (93.1%) at 12 months - higher MTA success rate
• Lindeboom et al.: MTA (92%) vs. IRM (86%) - MTA significantly better
• Four RCTs provided evidence that MTA significantly increases radiographic success compared to no root-end preparation/filling (gutta-percha smoothed control)
• Outcomes with MTA are similar to IRM and Super EBA clinically, but biocompatibility and tissue response are superior with MTA
• Only one systematic review found (classified as Level of Evidence 2); quasi-controlled + RCTs (Camilleri Book, Ch. 9)

Clinical Steps for Root-End Filling with MTA

1. Apical surgery with osteotomy, root-end resection (3 mm; 90° bevel)
2. Root-end cavity preparation (3 mm deep; ultrasonic tips preferred)
3. Dry cavity; MTA mixed to putty consistency
4. Carrier technique: place MTA into cavity, compact with micro-plugger
5. Verify adaptation with magnification (surgical microscope)
6. Replace flap; suture; post-operative instructions (Camilleri Book, Ch. 9)

---

5.7 REGENERATIVE ENDODONTICS - MTA AS CORONAL SEAL

• MTA plays a critical role as the coronal plug in regenerative endodontic procedures (REPs/revascularization) for necrotic immature permanent teeth
• After disinfection and blood clot/scaffold formation, MTA (3 mm thickness) is placed at the CEJ level as a cervical plug - seals the regenerative environment from oral contamination
• White MTA preferred to avoid discoloration of the clinical crown (Torabinejad Book, Ch. 6)

Regenerative Protocol (Torabinejad Book, Ch. 6)

1. Access preparation; minimal debridement (preserve Hertwig's epithelial root sheath)
2. Copious irrigation: 1.5% NaOCl (20 mL/canal); then saline; then 2% CHX
3. Dry with paper points
4. Place Ca(OH)₂ or triple antibiotic paste (TAP: metronidazole + ciprofloxacin + minocycline) as intracanal medicament
5. Seal temporarily; appointments 2-4 weeks later

1. Confirm: absence of symptoms (no pain, swelling, sinus tract)
2. Remove medicament; re-irrigate gently (EDTA 17% to remove smear layer and medicament; avoid NaOCl at this stage - may damage stem cells)
3. Dry with paper points
4. Create apical bleeding: Instrument 2 mm beyond apex to provoke bleeding into canal
5. Allow blood clot to form at CEJ level (~15 min)
6. Place MTA (3 mm) over clot at CEJ
7. Moist cotton pellet; seal with GIC + composite restoration
8. Follow up: continued root development expected:
   • Increased root length
   • Increased dentinal wall thickness
   • Apex closure (apexogenesis-like outcome) (Torabinejad Book, Ch. 6)

Rationale for MTA in REP

• MTA provides hermetic seal preventing oral recontamination of the regenerating tissue
• Biocompatibility with stem cells of the apical papilla (SCAP) - critical cell source for regeneration
• Hard tissue response from MTA does not interfere with root development processes (Torabinejad Book, Ch. 6)

---

5.8 MAINTENANCE OF PRIMARY TEETH WITHOUT PERMANENT SUCCESSORS

• MTA used to completely fill the root canal system of primary teeth lacking permanent successors (congenital absence of premolars - hypodontia)
• After pulpectomy-type preparation and debridement, entire canal filled with MTA - avoiding extrusion into periapical region
• Rationale: long-term maintenance of primary teeth as natural space maintainers; avoid conventional gutta-percha (not resorb appropriately)
• MTA supports periapical healing and maintenance of alveolar bone around tooth (Camilleri Book, Ch. 6)

---

5.9 DENS INVAGINATUS

• Dens invaginatus is a developmental anomaly modifying both crown and root; most common in maxillary lateral incisors
• Oehler classification (cited in Camilleri Book, Ch. 6):
  • Type I: cervical third
  • Type II: middle third
  • Type III: apical third - may communicate with the pulp cavity, leading to pulp compromise and periapical lesion
• MTA applications in dens invaginatus:
  • MTA apical plug where apex is open
  • MTA retrograde filling if endodontic surgery required
  • Filling entire canal with MTA where root anatomy is too aberrant for conventional obturation (Camilleri Book, Ch. 6)
• Management options: prophylactic sealing, conventional endodontics, endodontic surgery, or combination

---

6. DISCOLORATION - A KEY PEDIATRIC CONCERN

• Gray MTA (GMTA): Caused significant tooth discoloration - clinically unacceptable in anterior esthetic zone; not recommended for coronal placements in anterior teeth
• White MTA (WMTA): Developed to overcome this; however, discoloration has still been reported
• Mechanism of discoloration:
  • Bismuth oxide (Bi₂O₃) reacts with NaOCl → dark bismuth compounds (bismuth chloride, bismuth sulfide)
  • Oxidation products of iron (in GMTA)
  • Felman & Parashos (2013) - reported coronal discoloration with WMTA
• Pediatric management strategy:
  • WMTA preferred for anterior teeth in children
  • For posterior primary molars where esthetics are less critical, GMTA remains acceptable
  • Alternative: Use Biodentine (contains no bismuth oxide) - no discoloration risk; especially recommended for anterior teeth in children (Camilleri Book, Ch. 8)

---

7. COMPARISON WITH CALCIUM SILICATE ALTERNATIVES

---

8. DISADVANTAGES AND LIMITATIONS

1. Long setting time (2.5-4 hours with ProRoot) - requires second appointment for final restoration in most protocols
2. Tooth discoloration - especially with GMTA and when in contact with NaOCl; aesthetically problematic in anterior zone
3. Difficult manipulation - sandy, granular, non-adhesive consistency; difficult to place precisely in confined spaces
4. High cost compared to calcium hydroxide, formocresol, and ferric sulfate
5. Not easily retrievable once fully set
6. Slight solubility over time may create microscopic voids
7. Effect of contaminants - blood, saliva, irrigants (EDTA, CHX, BioPure MTAD) may compromise setting properties
8. No antimicrobial substantivity - antibacterial effect diminishes as pH equilibrates; unlike Ca(OH)₂ which provides sustained slow release (Torabinejad Book, Ch. 4; Camilleri Book, Ch. 1)

---

9. CONTRAINDICATIONS AND PRECAUTIONS IN PEDIATRIC CONTEXT

• Not recommended in teeth with:
  • Irreversible pulpitis extending into radicular pulp (in primary teeth → pulpectomy/extraction)
  • Severe periradicular infection not amenable to conservative treatment
  • Non-restorable teeth (treatment not viable)
  • Advanced physiological root resorption (>1/3 root length in primary teeth)
• Rubber dam isolation is mandatory - contamination with saliva compromises setting chemistry and clinical outcome
• Avoid excessive air drying of pulp surface - desiccation damages remaining pulp cells
• Adequate hemostasis must be achieved before MTA placement - blood contamination in excess may interfere with setting
• Discoloration counseling mandatory before placement in esthetic areas (Torabinejad Book, Ch. 4)

---

10. IDEAL PROPERTIES OF A PULP CAPPING/REPAIR MATERIAL (MTA vs. Ideal)

---

---

PART 2: LANDMARK AND RECENT LITERATURE SUPPORT

---

A. LANDMARK STUDIES (Historical Foundation)

A.1 Development and Original Introduction of MTA

• Significance: The founding paper introducing MTA to dentistry. First demonstrated superior sealing ability compared to amalgam in a dye leakage model. This paper established MTA as a serious root-end filling candidate and launched two decades of research.

• Significance: Characterized setting time, compressive strength, solubility, and radiopacity; established that MTA possessed superior physical properties to contemporary root-end filling materials; foundational material science data.

• Significance: Established that set MTA is significantly less cytotoxic than freshly mixed MTA; demonstrated biocompatibility of the hardened material; foundational safety and biocompatibility data for all subsequent clinical applications.

• Significance: First comprehensive clinical review codifying all MTA applications - pulp capping, pulpotomy, apexification, perforation repair, and root-end filling. The landmark paper that introduced MTA to the clinical mainstream and is among the most cited endodontic papers ever published.

---

A.2 MTA in Pediatric Applications - Landmark Studies

• Significance: Pioneering clinical study directly relevant to pediatric dentistry demonstrating MTA's superiority over amalgam for furcal perforation repair; established MTA as material of choice for this application; seminal for pediatric endodontics.

• Significance: First clinical study on MTA pulp capping; established clinical protocol and early evidence of success; foundational for all subsequent vital pulp therapy with MTA work.

• Significance: First RCT specifically comparing MTA with formocresol in primary molars; MTA showed 100% clinical and 97% radiographic success vs. 100% clinical and 93% radiographic success for formocresol; established MTA as a viable and superior alternative to formocresol in primary molar pulpotomy; pivotal paper in pediatric endodontics.

• Significance: 56-month (nearly 5-year) follow-up study; MTA pulpotomy success 92% vs. formocresol 76%; confirmed long-term superiority of MTA; demonstrated that MTA maintains furcation integrity and significantly reduces internal root resorption compared to formocresol; one of the most cited pediatric endodontic papers.

• Significance: Prospective randomized study confirming significantly better outcomes with MTA vs. formocresol; confirmed superiority in preventing internal root resorption; strengthened evidence base for MTA replacing formocresol in primary molar pulpotomy.

---

A.3 MTA Apexification - Landmark Evidence

• Significance: Animal study demonstrating MTA produced superior apical closure compared to Ca(OH)₂ in dog teeth with open apices; established biological basis for MTA apical plug technique in pediatric endodontics.

• Significance: Clinical case series establishing single-visit MTA apical plug technique; contrasted dramatically with multi-visit Ca(OH)₂ approach; major advance in the management of non-vital immature permanent teeth in children; transformed clinical practice for pediatric endodontics.

---

A.4 Bioactivity - Foundational Mechanism

• Significance: Defined the hydroxyapatite interface mechanism of MTA - first paper to explain the physicochemical basis for bioactivity, superior sealing ability, and hard tissue induction; proposed that Ca²⁺ from MTA reacts with tissue phosphate → hydroxyapatite → biological seal; one of the most cited MTA mechanism papers; foundational for understanding how MTA works at the tissue interface.

---

B. RECENT HIGH-QUALITY EVIDENCE (Systematic Reviews and Meta-Analyses, 2017-2025)

B.1 Vital Pulp Therapy in Primary Teeth

• Findings: Comprehensive meta-analysis of vital pulp therapy in primary teeth; MTA and ferric sulfate showed higher clinical and radiographic success rates than formocresol; MTA demonstrated clinical success 97%; radiographic success 94% at 24 months. MTA recommended as a superior alternative to formocresol.
• Clinical Implication: MTA endorsed as first-line material for primary molar pulpotomy; evidence supports its adoption over formocresol.

• Findings: High-quality Cochrane review covering all pulp treatments for primary teeth; MTA and ferric sulfate produced similar high success rates; very low-to-moderate certainty evidence limits definitive ranking; formocresol remains in use despite biological concerns; insufficient direct comparison RCT data to firmly rank materials.
• Clinical Implication: Need for more high-quality direct comparison RCTs; current evidence favors MTA but certainty is moderate.

• Findings: Both MTA and Biodentine showed similarly high clinical and radiographic success rates in primary molar pulpotomy; no statistically significant difference between the two; Biodentine advantages: no discoloration, 9-12 minute setting time (vs. hours for MTA). Trial sequential analysis confirmed adequate evidence.
• Clinical Implication: Biodentine is a clinically equivalent alternative to MTA; in anterior primary teeth where discoloration is a major concern, Biodentine is preferred.

• Findings: MTA pulpotomy showed highest success rates (clinical 97.3%; radiographic 93.4%) among all pulpotomy materials tested including formocresol, ferric sulfate, and Ca(OH)₂; confirmed MTA as best evidence-based material for primary tooth pulpotomy.

• Findings: Updated meta-analysis (2023 update to Coll 2017); MTA continues to demonstrate superiority in vital pulp therapy; network meta-analysis places MTA and calcium silicate cements at the top for overall success across all primary tooth vital pulp interventions.

• Findings: Current AAPD-supported guidelines; endorses MTA and Biodentine as first-line agents for primary molar pulpotomy; formally moves away from formocresol as historical gold standard.
• Clinical Implication: This represents the highest level of clinical recommendation available in pediatric dentistry - guideline-level endorsement of MTA.

• Findings: Most recent (2025) head-to-head systematic review and meta-analysis; no significant difference between Biodentine and MTA in clinical and radiographic success in primary molar pulpotomy; both show >90% success rates at all time points.
• Clinical Implication: Material selection between MTA and Biodentine should be guided by cost, setting time, and esthetic requirements rather than efficacy. In anterior teeth or when fast setting is required, Biodentine is preferred. In cases where maximum evidence history is desired, MTA remains the gold standard.

---

B.2 Vital Pulp Therapy in Immature/Young Permanent Teeth

• Findings: At 12-month follow-up, MTA = 100% success; Biodentine = 93.3%; Ca(OH)₂ = 66.7% for direct pulp capping in young permanent teeth with carious exposures; MTA produced highest rates of dentin bridge formation.
• Clinical Implication: Strong RCT evidence that MTA and Biodentine should replace Ca(OH)₂ for direct pulp capping in children's developing permanent teeth.

• Findings: Overall success rate of pulpotomy in permanent teeth with irreversible pulpitis was 81.7%; MTA-based treatments showed high success rates; pulpotomy using bioceramics is a valid alternative to root canal treatment in carefully selected pediatric/young adult cases.

• Findings: MTA and calcium silicate cements significantly outperform calcium hydroxide for both pulpotomy and direct pulp capping outcomes; network meta-analysis confirms MTA/calcium silicates at highest rank for success.

---

B.3 Apexification

• Findings: MTA apexification achieved significantly faster clinical resolution than Ca(OH)₂ apexification (1-2 visits vs. months-years); no significant difference in final success rates; MTA avoids risks of prolonged Ca(OH)₂ treatment (root fracture, non-compliance, calcium hydroxide collagen hydrolysis).
• Clinical Implication: MTA apical plug is the preferred method for apexification - fewer visits, more predictable outcomes, lower risk of root fracture.

• Findings: MTA showed significantly higher overall success rate (93.5%) compared to Ca(OH)₂ (85.0%) for apexification; MTA significantly reduced treatment time; confirmed MTA as first-line treatment for apexification in immature permanent teeth.

• Findings: Compared MTA apical plug, Ca(OH)₂ apexification, and regenerative endodontics; all three approaches achieve healing; MTA apical plug provides faster treatment and reliable apical seal; regenerative endodontics offers potential for continued root development and is preferred in younger patients when feasible.
• Clinical Implication: Choice of treatment should consider tooth age, remaining root structure, and feasibility of regenerative protocols. In very young patients with large, open apices, REP is preferred. When REP fails or is not feasible, MTA plug is the reliable standard.

---

C. CURRENT STATUS AND EVOLVING EVIDENCE (2024-2026)

C.1 AAPD 2024 Guidelines

• The 2024 AAPD guidelines (Coll et al., Pediatr Dent. 2024, PMID: 38449041) formally endorse MTA and calcium silicate cements as first-line agents for primary molar pulpotomy, displacing formocresol from its historical gold standard position. This represents a paradigm shift in pediatric endodontics practice.

C.2 Bioceramic Alternatives Emerging

• 2025 RCT (Ghaly et al., Sci Rep. 2025, PMID: 40691703): Evaluated bioceramic putty (EndoSequence/iRoot) as an apical plug in non-vital immature anterior permanent teeth; showed clinical and radiographic outcomes comparable to ProRoot MTA; may offer advantages (premixed, no Bi₂O₃, fast setting).

C.3 Regenerative Endodontics vs. MTA Apical Plug

• Growing evidence and AAE/AAPD guidelines favor regenerative endodontic procedures (REPs) over MTA apical plug in younger patients with immature roots - REPs offer potential for biological root maturation (increased wall thickness, apex closure)
• MTA plug remains the standard fallback when REP is not feasible or has failed
• No head-to-head RCTs comparing REP vs. MTA plug long-term tooth survival in immature permanent teeth exist yet

C.4 Discoloration Solutions

• Continued use of WMTA is complicated by ongoing discoloration reports when in contact with NaOCl
• Biodentine and bioceramic materials (no bismuth oxide) are increasingly adopted for anterior teeth in children where discoloration is absolutely unacceptable
• This trend is supported by the 2019 SR by Nagendrababu et al. showing non-inferior outcomes with Biodentine vs. MTA (PMID: 30926099)

---

D. SUMMARY EVIDENCE TABLE

---

E. EXAMINER'S QUICK RECALL CHECKLIST

1. Indirect pulp capping
2. Direct pulp capping (mechanical exposures primary teeth; carious exposures young permanent teeth)
3. Pulpotomy - primary teeth (replaces formocresol)
4. Partial/Full pulpotomy - immature permanent teeth (apexogenesis)
5. Apexification - MTA apical plug (immature permanent teeth; necrotic pulp)
6. Root perforation repair (furcal perforations in primary/permanent teeth)
7. Root-end filling (periapical surgery)
8. Regenerative endodontics (cervical coronal plug)
9. Primary tooth maintenance (no successor) + Dens invaginatus

• PMID 38449041 - AAPD 2024 guideline endorsing MTA (highest recommendation level)
• PMID 28292337 - Coll SR 2017 (primary tooth VPT meta-analysis)
• PMID 41290279 - Lu 2025 (MTA vs. Biodentine, most recent)
• PMID 26911724 - Lin 2016 (apexification SR - MTA 93.5% success)
• PMID 11242755 - Eidelman 2001 (first RCT MTA vs. formocresol)
• PMID: 7506137 - Torabinejad 1993 (founding MTA paper)